S&P 500   4,290.32 (+0.38%)
DOW   34,010.93 (+0.09%)
QQQ   329.62 (+0.34%)
AAPL   174.26 (-0.17%)
MSFT   291.15 (-0.06%)
META   175.38 (+0.30%)
GOOGL   120.56 (+0.84%)
AMZN   142.25 (+0.11%)
TSLA   911.13 (-0.09%)
NVDA   187.58 (+2.31%)
NIO   19.92 (-0.80%)
BABA   90.84 (+1.19%)
AMD   100.59 (+2.36%)
MU   63.07 (+2.35%)
T   18.52 (+0.54%)
CGC   3.74 (-7.88%)
F   16.17 (+0.87%)
GE   79.42 (-0.63%)
DIS   122.83 (+0.02%)
AMC   19.60 (-8.24%)
PYPL   100.43 (+1.02%)
PFE   48.62 (-1.32%)
NFLX   244.77 (+1.50%)
S&P 500   4,290.32 (+0.38%)
DOW   34,010.93 (+0.09%)
QQQ   329.62 (+0.34%)
AAPL   174.26 (-0.17%)
MSFT   291.15 (-0.06%)
META   175.38 (+0.30%)
GOOGL   120.56 (+0.84%)
AMZN   142.25 (+0.11%)
TSLA   911.13 (-0.09%)
NVDA   187.58 (+2.31%)
NIO   19.92 (-0.80%)
BABA   90.84 (+1.19%)
AMD   100.59 (+2.36%)
MU   63.07 (+2.35%)
T   18.52 (+0.54%)
CGC   3.74 (-7.88%)
F   16.17 (+0.87%)
GE   79.42 (-0.63%)
DIS   122.83 (+0.02%)
AMC   19.60 (-8.24%)
PYPL   100.43 (+1.02%)
PFE   48.62 (-1.32%)
NFLX   244.77 (+1.50%)
S&P 500   4,290.32 (+0.38%)
DOW   34,010.93 (+0.09%)
QQQ   329.62 (+0.34%)
AAPL   174.26 (-0.17%)
MSFT   291.15 (-0.06%)
META   175.38 (+0.30%)
GOOGL   120.56 (+0.84%)
AMZN   142.25 (+0.11%)
TSLA   911.13 (-0.09%)
NVDA   187.58 (+2.31%)
NIO   19.92 (-0.80%)
BABA   90.84 (+1.19%)
AMD   100.59 (+2.36%)
MU   63.07 (+2.35%)
T   18.52 (+0.54%)
CGC   3.74 (-7.88%)
F   16.17 (+0.87%)
GE   79.42 (-0.63%)
DIS   122.83 (+0.02%)
AMC   19.60 (-8.24%)
PYPL   100.43 (+1.02%)
PFE   48.62 (-1.32%)
NFLX   244.77 (+1.50%)
S&P 500   4,290.32 (+0.38%)
DOW   34,010.93 (+0.09%)
QQQ   329.62 (+0.34%)
AAPL   174.26 (-0.17%)
MSFT   291.15 (-0.06%)
META   175.38 (+0.30%)
GOOGL   120.56 (+0.84%)
AMZN   142.25 (+0.11%)
TSLA   911.13 (-0.09%)
NVDA   187.58 (+2.31%)
NIO   19.92 (-0.80%)
BABA   90.84 (+1.19%)
AMD   100.59 (+2.36%)
MU   63.07 (+2.35%)
T   18.52 (+0.54%)
CGC   3.74 (-7.88%)
F   16.17 (+0.87%)
GE   79.42 (-0.63%)
DIS   122.83 (+0.02%)
AMC   19.60 (-8.24%)
PYPL   100.43 (+1.02%)
PFE   48.62 (-1.32%)
NFLX   244.77 (+1.50%)
LON:COG

Cambridge Cognition - COG Share Forecast, Price & News

GBX 133.50
0.00 (0.00%)
(As of 08/18/2022 05:06 PM ET)
Add
Compare
Today's Range
130
137
50-Day Range
104.95
138.40
52-Week Range
98.80
189.88
Volume
5,595 shs
Average Volume
45,600 shs
Market Capitalization
£41.61 million
P/E Ratio
13,350.00
Dividend Yield
N/A
Price Target
N/A
COG stock logo

About Cambridge Cognition (LON:COG) Stock

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Cambridge Cognition Trading Up 2.6 %

Shares of LON:COG traded up GBX 3.50 ($0.04) during mid-day trading on Thursday, reaching GBX 137 ($1.66). 4,915 shares of the company were exchanged, compared to its average volume of 45,596. The firm has a market cap of £42.70 million and a price-to-earnings ratio of 13,350.00. The company has a debt-to-equity ratio of 2.85, a current ratio of 1.01 and a quick ratio of 0.87. Cambridge Cognition has a 1 year low of GBX 98.80 ($1.19) and a 1 year high of GBX 189.88 ($2.29). The firm's 50-day simple moving average is GBX 121.95 and its 200 day simple moving average is GBX 133.23.

Insider Buying and Selling

In related news, insider Matthew Stork acquired 22,950 shares of Cambridge Cognition stock in a transaction dated Thursday, July 21st. The shares were acquired at an average cost of GBX 113 ($1.37) per share, for a total transaction of £25,933.50 ($31,335.79).

Receive COG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter.

COG Stock News Headlines

Cambridge Cognition moves into profit after above market growth
RTC Group dives as Covid-19 hits 2021 profitability
Cambridge Cognition advances after autoimmune contract win
SpectrumX makes two key appointments ahead of late-spring IPO
See More Headlines
Receive COG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambridge Cognition and its competitors with MarketBeat's FREE daily newsletter.

COG Company Calendar

Last Earnings
9/22/2020
Today
8/18/2022
Next Earnings (Estimated)
9/20/2022

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
58
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£10.09 million
Cash Flow
GBX 21.90 per share
Book Value
GBX 2 per share

Miscellaneous

Free Float
N/A
Market Cap
£41.61 million
Optionable
Optionable
Beta
N/A

Key Executives

  • Dr. Matthew Stork
    CEO & Director
  • Mr. John Hammond
    Co-Founder
  • Mr. Stephen Daniel Symonds (Age 47)
    CFO & Exec. Director
  • Mr. Nick Taptiklis
    Head of Technology Strategy
  • Ms. Francesca Cormack Ph.D.
    Chief Scientist
  • Mr. Simon Merritt
    Marketing and Communications Director
  • Dr. Lisa Elizabeth Nolan Ph.D. (Age 60)
    VP Bus. Devel.
  • Ms. Nicky Ackerley
    Global HR Director
  • Prof. Trevor Robbins
    Sr. Consultant
  • Prof. Barbara Sahakian FMedSci
    FBPsS, Sr. Consultant













COG Stock - Frequently Asked Questions

How have COG shares performed in 2022?

Cambridge Cognition's stock was trading at GBX 130 at the beginning of the year. Since then, COG stock has increased by 4.3% and is now trading at GBX 135.65.
View the best growth stocks for 2022 here
.

When is Cambridge Cognition's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 20th 2022.
View our COG earnings forecast
.

How were Cambridge Cognition's earnings last quarter?

Cambridge Cognition Holdings Plc (LON:COG) posted its quarterly earnings data on Tuesday, September, 22nd. The company reported ($1.50) earnings per share for the quarter.

What other stocks do shareholders of Cambridge Cognition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambridge Cognition investors own include Interserve (IRV), Alio Gold Inc. (ALO.TO) (ALO), Concepta PLC (CPT.L) (CPT), European Metals (EMH), IntelGenx Technologies (IGXT), Oxford Biomedica (OXB), Syneos Health (SYNH), Travelers Companies (TRV), Amryt Pharma (AMYT) and AltynGold (ALTN).

What is Cambridge Cognition's stock symbol?

Cambridge Cognition trades on the London Stock Exchange (LON) under the ticker symbol "COG."

How do I buy shares of Cambridge Cognition?

Shares of COG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cambridge Cognition's stock price today?

One share of COG stock can currently be purchased for approximately GBX 135.65.

How much money does Cambridge Cognition make?

Cambridge Cognition (LON:COG) has a market capitalization of £42.28 million and generates £10.09 million in revenue each year.

How can I contact Cambridge Cognition?

Cambridge Cognition's mailing address is Tunbridge Court Tunbridge Lane, Bottisham, CAMBRIDGE, CB25 9TU, United Kingdom. The official website for the company is www.cambridgecognition.com. The company can be reached via phone at 44 1223 810 700.

This page (LON:COG) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.